Biotech
Biotech

Ozempic’s patent cliff is about to change the global drug market

Semaglutide's primary patents expire between 2026 and 2031, opening the market to biosimilars.

Spec'd Editorial . . 1 min
Spec'd Editorial
Written by
Spec'd Editorial

Editorial desk for The Spec'd — technology coverage at full resolution. Published by Hyphn Media Inc., Toronto.

More from this author
Keep reading
Biotech

The protein folding revolution, three years later: what AlphaFold actually changed

DeepMind's structure prediction tool has been used in 2 million research projects.

Apr 23, 2026 . 1 min
Biotech

GLP-1 drugs are now being used for addiction. The research is startling.

Semaglutide and tirzepatide are showing strong efficacy against alcohol, nicotine, and opioid addiction in early trials.

Apr 23, 2026 . 1 min
Biotech

mRNA flu vaccines are coming — here’s what the trials show

After COVID mRNA vaccines, Moderna and Pfizer have completed Phase 3 trials for influenza with substantially better efficacy.

Apr 23, 2026 . 1 min

Leave a Reply

Your email address will not be published. Required fields are marked *